All articles by Vidya Sagar Maddela
Vidya Sagar Maddela
BTL, JANZ partner to provide medical solutions to US military and veterans
Under the partnership, JANZ will allow BTL Industries to provide its advanced Emsculpt Neo technology to military and veteran communities, to reduce the risk of injury in combat and improve the quality of life
ALVERNO LABORATORIES LAUNCHES INTO THE ERA OF AI-POWERED PATHOLOGY WITH IBEX MEDICAL ANALYTICS
Alverno is the first laboratory in the Midwest region of the United States to deploy AI in routine practice to improve the quality of care for its community.
CluePoints rolls out two new AI solutions to improve clinical trials
The Site Profile and Oversight Tool (SPOT) allows care teams to rapidly pinpoint anomalies and translate insights into strategies and actions, and the Intelligent Medical Coding tool will improve accuracy and efficiency in clinical trials
Gyros Protein Technologies Introduces Gyrolab Generic Anti-AAV Kit to Support Gene Therapy Development
Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays
SpineThera collaborates with Mayo Clinic to advance drug abuse treatment
The collaboration will leverage SpineThera’s long-acting injectable technology and Mayo Clinic’s expertise in addiction medicine, to develop long-acting injectable drugs to improve treatment outcomes for individuals with substance abuse disorders
CHOP researchers discover new biomarker to early detect ovarian cancer
The study by researchers at CHOP and UT Southwestern Medical Center showed that a healthier immune system reacts with a stronger response in the early stages of HGOC, producing a measurable biomarker
Trustworthy and Responsible AI Network expands into Europe
European TRAIN will include Erasmus MC, HUS Helsinki University Hospital, Sahlgrenska University Hospital, Skåne University Hospital, Universita Vita-Salute San Raffaele and University Medical Center Utrecht, along with Foundation 29
MTF Biologics, Centurion expand partnership to advance wound care
The expanded collaboration will provide clinicians and patients with access to advanced wound care technologies, along with ongoing training, marketing, and support, for the effective promotion and distribution
Viz.ai, HCMA partner to improve care for hypertrophic cardiomyopathy patients
HCM is a genetic heart muscle disorder characterised by thickened heart muscles, making it harder for the heart to pump blood, and is associated with the risk of atrial fibrillation, mitral valve disease, and heart failure
Getinge secures FDA 510(k) approval for its Talis +ACG software
Talis +ACG (Advanced Clinical Guidance) comprises Talis-Anesthesia, Talis-Perfusion, Talis-RemoteView, and Talis-ECMO applications and promotes compliance with care protocols directly at the bedside in high-acuity care environments